P46 LOW DOSE CYCLOPHOSPHAMIDE AS AN INDUCTION AGENT IN PROLIFERATIVE LUPUS NEPHRITIS PATIENTS IN CENTRAL INDIA - AN AFFORDABLE & VIABLE OPTION

P46 LOW DOSE CYCLOPHOSPHAMIDE AS AN INDUCTION AGENT IN PROLIFERATIVE LUPUS NEPHRITIS PATIENTS IN CENTRAL INDIA - AN AFFORDABLE & VIABLE OPTION

Bibliographic Details
Main Authors:	M. Balwani, C. Bawankule, R. Yadav, N. Ambade
Format:	Article
Language:	English
Published:	Elsevier 2016-11-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024916301310

Similar Items

Mycophenolate versus cyclophosphamide for lupus nephritis
by: M Sahay, et al.
Published: (2018-01-01)

Fish oil enhanced the efficacy of low-dose cyclophosphamide regimen for proliferative lupus nephritis: a randomized controlled double-blind trial
by: Chi Zhang, et al.
Published: (2021-07-01)

TO COMPARE THE EFFICACY OF MYCOPHENOLATEMOFETYL WITH CYCLOPHOSPHAMIDE IN THE MANAGEMENT OF LUPUS NEPHRITIS
by: Dilshad Muhammad, et al.
Published: (2014-12-01)

Non-histologic factors discriminating proliferative lupus nephritis from membranous lupus nephritis
by: Oh Chan Kwon, et al.
Published: (2020-06-01)

Low dose mycophenolate mofetil versus cyclophosphamide in the induction therapy of lupus nephritis in Nepalese population: a randomized control trial
by: Arun Sedhain, et al.
Published: (2018-07-01)

Comparing the Efficacy and Safety of Induction Therapies for the Treatment of Patients with Proliferative Lupus Nephritis in South Africa
by: Phelisa Sogayise, et al.
Published: (2020-01-01)

Mycophenolate or cyclophosphamide in lupus nephritis: Which one to use in Indian patients?
by: Manish Rathi, et al.
Published: (2018-01-01)

Comparison of high and low dose of cyclophosphamide in lupus nephritis patients: A long-term randomized controlled trial
by: Ahmed H Mitwalli, et al.
Published: (2011-01-01)

P34 DUAL BLOCKADE OF THE HOMEOSTATIC CHEMOKINE CXCL12 AND THE PRO-INFLAMMATORY CHEMOKINE CCL2 IS AS EFFECTIVE AS CYCLOPHOSPHAMIDE IN PROLIFERATIVE LUPUS NEPHRITIS
by: S.K. Devarapu, et al.
Published: (2016-11-01)

Comparison of two steroid regimens in induction therapy of proliferative lupus nephritis: A randomized controlled trial
by: Joyita Bharati, et al.
Published: (2019-01-01)

A Predictive Model for Estimation Risk of Proliferative Lupus Nephritis
by: Dong-Ni Chen, et al.
Published: (2018-01-01)

Diffuse proliferative crescentic lupus nephritis with normal renal function
by: Vibhanshu Gupta, et al.
Published: (2012-01-01)

Anti-Myeloperoxidase Antibodies Associate with Future Proliferative Lupus Nephritis
by: S. W. Olson, et al.
Published: (2017-01-01)

Glutathione S Transferases Polymorphisms Are Independent Prognostic Factors in Lupus Nephritis Treated with Cyclophosphamide.
by: Alexandra Audemard-Verger, et al.
Published: (2016-01-01)

The Steroids in the Maintenance of Remission of Proliferative Lupus Nephritis (SIMPL) Pilot Trial
by: Lauren Galbraith, et al.
Published: (2014-11-01)

POS-243 THE VALUE OF AUTOANTIBODIES AS PREDICTORS FOR PROLIFERATIVE LUPUS NEPHRITIS CLASSES
by: N. LADHARI, et al.
Published: (2021-04-01)

07 Lessons from transplantation: Multitargeted therapy for proliferative lupus nephritis
by: Daniel Tak Mao Chan
Published: (2021-04-01)

INTRAVENOUS PULSE CYCLOPHOSPHAMIDE TREATMENT OF LUPUS NEPHRITIS: A RETROSPECTIVE TEN YEARS STUDY
by: R. Ganji., et al.
Published: (1997-06-01)

INTRAVENOUS PULSE CYCLOPHOSPHAMIDE TREATMENT OF LUPUS NEPHRITIS: A RETROSPECTIVE TEN YEARS STUDY
by: R. Ganji., et al.
Published: (1997-06-01)

Developing consensus treatment plans for proliferative lupus nephritis in childhood-onset systemic lupus erythematous
by: Mina Rina, et al.
Published: (2012-07-01)

Is rituximab effective for induction of remission in lupus nephritis?
by: Macarena Mac-Namara, et al.
Published: (2014-08-01)

Factores predictores de la respuesta a la terapia de inducción con ciclofosfamida en nefritis lúpica proliferativa Predictive factors of response to cyclophosphamide-based induction therapy for proliferative lupus nephritis
by: Miguel H. Estévez del Toro, et al.
Published: (2007-06-01)

Sickle cell nephropathy with diffuse proliferative lupus nephritis: a case report
by: Trivedi Hargovind L, et al.
Published: (2008-02-01)

Urinary TWEAK Level as a Marker of Lupus Nephritis Activity in 46 Cases
by: Zhu Xuejing, et al.
Published: (2012-01-01)

Understanding lupus nephritis: diagnosis, management, and treatment options
by: Mok CC
Published: (2012-05-01)

Effective use of rituximab in combination with low dose cyclophosphamide in childhood onset systemic lupus erythematosus (SLE) with relapsing class IV nephritis
by: Miettunen PM, et al.
Published: (2008-09-01)

Clinical and histopathological profile of lupus nephritis and response to treatment with cyclophosphamide: A single center study
by: Manjuri Sharma, et al.
Published: (2019-01-01)

Combination Therapy With Pulse Cyclophosphamide Plus Corticosteroids Improves Renal Outcome In Patients With Lupus Nephritis
by: H. Mansouri Torghabeh, et al.
Published: (2005-08-01)

Effect of Intravenous Cyclophosphamide Pulse Therapy on Renal Functions and Histopathology in Patients with Severe Lupus Nephritis
by: Huraib Sameer, et al.
Published: (2000-01-01)

Retrospective comparison of cyclophosphamide and mycophenolate mofetil in lupus nephritis at Groote Schuur Hospital nephrology unit
by: Sogayise, Phelisa
Published: (2021)

Induction therapy and outcome of proliferative lupus nephritis in the top end of Northern Australia – a single centre study retrospective study
by: Abeyaratne, A., et al.
Published: (2022)

End of induction treatment outcomes with a novel cyclophosphamide-based regimen for severe lupus nephritis: Single-center experience from South India
by: V Jayaprakash, et al.
Published: (2020-01-01)

Clinical features, epidemiology, and short-term outcomes of proliferative lupus nephritis in Eastern India
by: D Sircar, et al.
Published: (2013-01-01)

Unexpected recovery from longterm renal failure in severe diffuse proliferative lupus nephritis
by: Ross Sophia, et al.
Published: (2012-08-01)

Mycophenolate mofetil or cyclophosphamide in indian patients with lupus nephritis: Which is better? A single-center experience
by: Satish Mendonca, et al.
Published: (2017-01-01)

Pilot study comparing the childhood arthritis and rheumatology research alliance consensus treatment plans for induction therapy of juvenile proliferative lupus nephritis
by: Jennifer C Cooper, et al.
Published: (2018-10-01)

POS-498 REFRACTORY AND RELAPSING LUPUS NEPHRITIS FOLLOWING CYCLOPHOSPHAMIDE INDUCTION: A DESCRIPTIVE RETROSPECTIVE STUDY OF TREATMENT APPROACHES AND OUTCOMES FROM SRI LANKA
by: D. WIJAYARATNE, et al.
Published: (2021-04-01)

Diagnostic Determinants of Proliferative Lupus Nephritis Based on Clinical and Laboratory Parameters: A Diagnostic Study
by: Aida Lydia, et al.
Published: (2018-06-01)

Establishing Clinical Variables towards the Development of Corticosteroid Treatment Algorithms in Pediatric Proliferative Lupus Nephritis
by: Chalhoub, Nathalie E.
Published: (2019)

Efficacy and safety of tacrolimus in induction therapy of patients with lupus nephritis
by: Zhou TB, et al.
Published: (2019-03-01)